Viatris To Bring In Plenty Of Brand Knowledge With New CEO Smith
Board Member Smith To Jump Quickly Into CEO Seat, Replacing Goettler
Only three months after joining Viatris’ board of directors, Scott Smith, famed for spearheading Celgene’s successful and lucrative Inflammation and Immunology division, has been announced as the company’s new CEO, beginning 1 April.
